User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 2 results.
    • Journal article
    Apixaban versus warfarin in patients with atrial fibrillation.
    Granger, Christopher B Alexander, John H McMurray, John J V Lopes, Renato D Hylek, Elaine M Hanna, Michael Al-Khalidi, Hussein R Ansell, Jack Atar, Dan Avezum, Alvaro Bahit, M Cecilia Diaz, Rafael Easton, J Donald Ezekowitz, Justin A Flaker, Greg Garcia, David Geraldes, Margarida Gersh, Bernard J Golitsyn, Sergey Goto, Shinya Hermosillo, Antonio G Hohnloser, Stefan H Horowitz, John Mohan, Puneet Jansky, Petr Lewis, Basil S Lopez-Sendon, Jose Luis Pais, Prem Parkhomenko, Alexander Verheugt, Freek W A Zhu, Jun Wallentin, Lars ARISTOTLE Committees and Investigators Deceuninck, Olivier[UCL] (2011) New England Journal of Medicine — Vol. 365, no.11, p. 981-92 (2011)
    • Journal article
    Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy : primary results of the SYNERGY randomized trial
    Ferguson, James J. Califf, Robert M. Antman, Elliott M. Cohen, Marc Grines, Cindy L. Goodman, Shaun Kereiakes, Dean J. Langer, Anatoly Mahaffey, Kenneth W. Nessel, Christopher C. Armstrong, Paul W. Avezum, Alvaro Aylward, Phil Becker, Richard C. Biasucci, Luigi Borzak, Steven Col, Jacques[UCL] Frey, Marty J. Fry, Ed Gulba, Dietrich C. Guneri, Sema Gurfinkel, Enrique Harrington, Robert Hochman, Judith S. Kleiman, Neal S. Leon, Martin B. Lopez-Sendon, Jose Luis Pepine, Carl J. Ruzyllo, Witold Steinhubl, Steven R. Teirstein, Paul S. Toro-Figueroa, Luis White, Harvey SYNERGY Trial Investigators (2004) JAMA : the journal of the American Medical Association — Vol. 292, no.1, p. 45-54 (2004)